IM Cannabis Corp. (IMCC)
3.08
-0.33
(-9.68%)
USD |
NASDAQ |
Aug 31, 16:00
3.08
0.00 (0.00%)
After-Hours: 20:00
IM Cannabis Shareholders Equity (Quarterly) : -3.904M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.904M |
| March 31, 2026 | -3.619M |
| December 31, 2025 | -2.721M |
| September 30, 2025 | 2.848M |
| June 30, 2025 | 2.581M |
| March 31, 2025 | 3.699M |
| December 31, 2024 | 3.646M |
| September 30, 2024 | 4.407M |
| June 30, 2024 | 5.165M |
| March 31, 2024 | 7.034M |
| December 31, 2023 | 10.97M |
| September 30, 2023 | 14.18M |
| June 30, 2023 | 15.81M |
| March 31, 2023 | 17.50M |
| December 31, 2022 | 16.72M |
| September 30, 2022 | 39.55M |
| June 30, 2022 | 137.65M |
| March 31, 2022 | 156.95M |
| December 31, 2021 | 159.31M |
| September 30, 2021 | 165.43M |
| June 30, 2021 | 114.95M |
| March 31, 2021 | 92.58M |
| December 31, 2020 | 8.710M |
| September 30, 2020 | 21.08M |
| June 30, 2020 | 19.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 18.45M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | -0.1596M |
| January 31, 2019 | 8.780M |
| October 31, 2018 | 8.795M |
| July 31, 2018 | 8.891M |
| April 30, 2018 | 8.855M |
| January 31, 2018 | 9.247M |
| October 31, 2017 | 8.816M |
| July 31, 2017 | 9.096M |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | 9.443M |
| January 31, 2015 | 2.397M |
| October 31, 2014 | 2.767M |
| July 31, 2014 | 2.933M |
| April 30, 2014 | 2.930M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| Teva Pharmaceutical Industries Ltd. | 7.753B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 35.64M |
| Purple Biotech Ltd. | 12.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.40M |
| Total Liabilities (Quarterly) | 21.37M |
| Debt to Equity Ratio | -2.497 |
| Current Ratio | 0.5552 |
| Net Debt Paydown Yield | 0.29% |